" /> Nephrotic syndrome, type 3 - CISMeF





Preferred Label : Nephrotic syndrome, type 3;

Symbol : NPHS3;

CISMeF acronym : NPHS3;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Nephrotic syndrome, early-onset, type 3;

Description : Nephrotic syndrome, a malfunction of the glomerular filter, is characterized clinically by proteinuria, edema, and end-stage renal disease (ESRD). Renal histopathology may show diffuse mesangial sclerosis (DMS) or focal segmental glomerulosclerosis (FSGS) (Hinkes et al., 2006). Most patients with NPHS3 show diffuse mesangial sclerosis on renal biopsy, which is a pathologic entity characterized by mesangial matrix expansion with no mesangial hypercellularity, hypertrophy of the podocytes, vacuolized podocytes, thickened basement membranes, and diminished patency of the capillary lumen (Gbadegesin et al., 2008). For a general phenotypic description and a discussion of genetic heterogeneity of nephrotic syndrome and FSGS, see NPHS1 (256300).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the phospholipase C, epsilon-1 gene (PLCE1, 608414.0001);

Laboratory abnormalities : Proteinuria; Hypoalbuminemia;

Prefixed ID : #610725;

Détails


Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.